ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer

Nature Reviews Urology, Published online: 04 October 2022; doi:10.1038/s41585-022-00664-4ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer

https://www.nature.com/articles/s41585-022-00664-4

Source: Nature Reviews Urology - October 4, 2022 Category: Urology & Nephrology Authors: Annette Fenner Source Type: research

More News: Cancer | Cancer & Oncology | Neoadjuvant Therapy | Prostate Cancer | Urology & Nephrology